This study assessed the safety and efficacy of ab interno implantation of iStent inject in combination with cataract surgery in patients with primary open-angle glaucoma. Source: AAO
Altaire Pharmaceuticals has voluntarily recalled 150 lots of 23 ophthalmic products due to the potential for nonsterility. Source: AAO
This week, a bevacizumab biosimilar wins FDA approval, doctors remove an entrapped eyelash from a conjunctival ulcer and Oxurion’s plasma kallikrein inhibitor resolves diabetic macular edema in a phase 1 study. Source: AAO
Investigators prospectively examined the association between the progression of retinopathy and kidney disease. Source: AAO
This study evaluated the overall prevalence, annual prevalence and incidence of dry eye disease in a large, representative population in the United States. Source: AAO
In this retrospective case series, investigators report the characteristics of and surgical approach to patients with restrictive diplopia following pterygium excision. Source: AAO
Eculizumab (Soliris), a first-in-class complement inhibitor, is now approved for AQP4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) following an expedited 6-month priority review. Source: AAO
Due to a lack of sterility assurance, the FDA has issued a warning not to use any sterile drug products—including bevacizumab (Avastin)—produced by Pacifico National Inc, doing business as AmEx Pharmacy in Melbourne, Florida. Source: AAO
Investigators evaluated a water-free cyclosporine formulation (CyclASol) for moderate to severe dry eye disease. Source: AAO
Investigators report outcomes of wavefront-guided photorefractive keratectomy (WG-PRK) for high astigmatism after keratoplasty. Source: AAO